Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 064593/0242 | |
| Pages: | 12 |
| | Recorded: | 08/15/2023 | | |
Attorney Dkt #: | 700228.402USPC |
Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE FOURTH INVENTOR'S NAME PREVIOUSLY RECORDED AT REEL: 059841 FRAME: 0848. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. |
|
Total properties:
1
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17772888
|
Filing Dt:
|
04/28/2022
|
Publication #:
|
|
Pub Dt:
|
04/20/2023
| | | | |
Title:
|
MLL1 INHIBITORS AND ANTI-CANCER AGENTS
|
|
Assignee
|
|
|
4218 JINKE ROAD |
PUDONG NEW AREA |
SHANGHAI, CHINA |
|
Correspondence name and address
|
|
QING LIN, PH.D.
|
|
SEED IP LAW GROUP LLP
|
|
701 5TH AVE, SUITE 5400
|
|
SEATTLE, WA 98104
|
Search Results as of:
05/02/2024 04:35 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|